The system will be going down for regular maintenance. Please save your work and logout.
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies
Language
en
Autre communication scientifique (congrès sans actes - poster - séminaire...)
This item was published in
65th Annual Meeting of the French Economic Association,, 2015-06-27, Nancy.
Origin
Hal imported